Cardiac β-adrenoceptor modulation by amiodarone
References (23)
- et al.
Am. Heart J.
(1981) - et al.
Biochem. Pharmac.
(1976) - et al.
J. biol. Chem.
(1951) - et al.
J. biol. Chem.
(1925) Biochem. Pharmac.
(1982)- et al.
Biochem. Pharmac.
(1981) - et al.
Arzneimittel-Forsch.
(1968) B. J. Pharmac.
(1970)- et al.
Naunyn-Schmiedeberg's Archs Pharmac.
(1981) - et al.
Naunyn-Schmiedeberg's Archs Pharmac.
(1982)
Cited by (64)
A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death
2006, Free Radical Biology and MedicineConcentration dependent mitochondrial effect of amiodarone
2003, Biochemical PharmacologyCitation Excerpt :Amiodarone (2-butyl-3-benzofuranyl-4-[2-(diethylamino)-ethoxy]-3,5-diiodophenyl-ketone hydrochloride), a class III antiarrhythmic agent prolongs action potential duration which effect may involve blocking of β-adrenergic receptors, sodium channels and L-type calcium channels [1–4].
The effect of amiodarone on the β-adrenergic receptor is due to a downregulation of receptor protein and not to a receptor-ligand interaction
1999, Biochemical and Biophysical Research CommunicationsCircadian variation of sustained ventricular tachycardia in patients sybject to standard adrenergic blockade
1997, American Heart JournalInhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
1996, Biochemical PharmacologyAntagonism between T<inf>3</inf> and amiodarone on the contractility and the density of β-adrenoceptors of chicken cardiac myocytes
1994, European Journal of Pharmacology
Copyright © 1983 Published by Elsevier Inc.